Borrelia miyamotoi

Last updated

Borrelia miyamotoi
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Spirochaetota
Class: Spirochaetia
Order: Spirochaetales
Family: Borreliaceae
Genus: Borrelia
Species:
B. miyamotoi
Binomial name
Borrelia miyamotoi
Fukunaga et al. 1995

Borrelia miyamotoi is a bacterium of the spirochete phylum in the genus Borrelia . A zoonotic organism, B. miyamotoi can infect humans through the bite of several species of hard-shell Ixodes ticks, the same kind of ticks that spread B. burgdorferi, the causative bacterium of Lyme disease. Ixodes ticks are also the primary vector in the spread of babesiosis and anaplasmosis. [1]

Contents

B. miyamotoi causes Borrelia miyamotoi disease (BMD) in humans. BMD is a relapsing fever illness that has been reported across the world, often in the same geographic areas where Lyme disease is endemic. [1] Treatment currently follows that of Lyme disease. [2]

Microbiology

History and morphology

B. miyamotoi was discovered in 1995 when it was isolated from a population of Ixodes persulcates ticks on the Japanese island of Hokkaido. [1] The organism was named for Kenji Miyamoto, who initially discovered Borrellia spirochetes in Japan. [3] It was first detected in the United States in 2001. [4]

B. miyamotoi is a gram-negative, anaerobic, obligate parasitic bacterium with a spiraling corkscrew shape. [1] [5]

Genetics

The bacterial genome is physically made up of one linear chromosome, twelve linear plasmids, and two circular plasmids, which encode a total of 1362 genes. Four distinct genotypes of B. miyamotoi have been demonstrated based on examples isolated from Asia, Europe, and North America. [2] [5]

Borrelia species that cause human disease are classified into two genetic clades, the Lyme borreliosis (LB) clade, and the relapsing fever (RF) clade. B. miyamotoi is a member of the relapsing fever (RF) clade. [5] The glpQ gene and its resulting GlpQ protein are conserved in the RF clade of Borrelia, which makes it possible to distinguish them from LB group Borrellia in testing. [5]

Transmission

Unlike B. burgdoferi, B. miyamotoi exhibits transovarial transmission, whereby the bacterium is passed from an adult tick directly into the eggs of new larvae within the ovaries. This mode of transmission has implications for diagnosis of disease because a very small larva can attach to a human host and go undetected. [1]

Virulence factors

B. myomotoi employs antigenic variation and variable membrane proteins (VMPs) that help it to evade the human immune system. [6] It is also known to evade components of the complement cascade, part of innate immune system, which mounts the initial response to an infection. [2] [7]

Disease

History

Borellia miyamotoi disease (BMD) in humans was first described in Russia in 2011, then subsequently in Japan, China, North America, Western Europe, and Asia. [2] [5]

Reservoirs

Several variations of mice and voles are known rodent reservoirs for B. miyamotoi, including Apodemus spp., Myodes glareolus, and Peromyscus leucopus. [2] There is also some preliminary evidence for various avian and several large animal reservoirs such as wild boar and deer. [2]

Vector

The primary vector for B. miyamotoi transmission is the hard-shell Ixodes tick. Specific species of the tick have been identified in different parts of the world. [1] [2] [5]

Ixodes species by region
RegionSpecies
China, Japan, RussiaIxodes persulcatus
Japan, RussiaIxodes pavlovski
Southeast AsiaIxodes ovatus
United StatesIxodes scapularis
United States (California)Ixodes pacificus
Western EuropeIxodes ricinus

Clinical presentation

BMD presents approximately two weeks after infection with non-specific flu-like symptoms including a relapsing-remitting fever in excess of 40C (104F), malaise, myalgias (muscle pain), arthralgias (joint pain), nausea, vomiting, and headache. Some patients may have elevated liver transaminases, thrombocytopenia, and leukopenia. [1] [2] [5] [6] Cases involving an erythema migrans rash, which is a classic feature of Lyme disease, have been reported, but are believed to likely be the result of co-infection with B. burgdorferi and the development of co-morbid Lyme disease. [2] B. miyamotoi has also demonstrated a slower onset neurological syndrome including meningitis in some immunocompromised patients. [2] [5]

Since ticks in all phases of their life cycle, including very small larvae, can transmit the disease to humans, the bite and tick can easily go undetected. [1] B. miyamotoi also transmits faster than B. burgdorfi, often within 24 hours of tick attachment. [1] [2]

Diagnosis

PCR tests are available for Borrelia Miyamotoi https://www.mayocliniclabs.com/test-catalog/overview/618298

Polymerase chain reaction (PCR) testing for the 16S ribosomal DNA, fla, or p66 genes have been used in specialized labs. [2] [5] PCR for the glpQ gene can be used to rule out Lyme disease since LB clade Borrelia species don't contain it, however a positive test doesn't necessarily indicate B. miyamotoi infection because the gene exists in all RF clade Borrelia species. [1] [2] [5]

An investigational method of detection involving combined serologic testing for IgG and IgM antibodies against both the GlpQ and VMP proteins has recently shown high sensitivity and specificity. [2] [5]

Treatment

Antibiotics used for Lyme disease are generally recommended for BMD. [8] Though no prospective studies nor formal guidelines have been developed, these antibiotics have been reported to be effective. [9] [8] Doxycycline or ceftriaxone are usually recommended. A possible resistance to amoxicillin was noted in an in vitro study, but the significance for humans is unknown. [9] [1] [2] The Jarisch-Herxheimer reaction has been noted at the start of antibiotic treatment for BMD. [2] [10] [9] [8]

Related Research Articles

<span class="mw-page-title-main">Lyme disease</span> Infectious disease caused by Borrelia bacteria, spread by ticks

Lyme disease, also known as Lyme borreliosis, is a vector-borne disease caused by Borrelia bacteria, which are spread by ticks in the genus Ixodes. The most common sign of infection is an expanding red rash, known as erythema migrans (EM), which appears at the site of the tick bite about a week afterwards. The rash is typically neither itchy nor painful. Approximately 70–80% of infected people develop a rash. Early diagnosis can be difficult. Other early symptoms may include fever, headaches and tiredness. If untreated, symptoms may include loss of the ability to move one or both sides of the face, joint pains, severe headaches with neck stiffness or heart palpitations. Months to years later, repeated episodes of joint pain and swelling may occur. Occasionally, shooting pains or tingling in the arms and legs may develop. Despite appropriate treatment, about 10 to 20% of those affected develop joint pains, memory problems, and tiredness for at least six months.

Tick-borne diseases, which afflict humans and other animals, are caused by infectious agents transmitted by tick bites. They are caused by infection with a variety of pathogens, including rickettsia and other types of bacteria, viruses, and protozoa. The economic impact of tick-borne diseases is considered to be substantial in humans, and tick-borne diseases are estimated to affect ~80 % of cattle worldwide. Most of these pathogens require passage through vertebrate hosts as part of their life cycle. Tick-borne infections in humans, farm animals, and companion animals are primarily associated with wildlife animal reservoirs. Many tick-borne infections in humans involve a complex cycle between wildlife animal reservoirs and tick vectors. The survival and transmission of these tick-borne viruses are closely linked to their interactions with tick vectors and host cells. These viruses are classified into different families, including Asfarviridae, Reoviridae, Rhabdoviridae, Orthomyxoviridae, Bunyaviridae, and Flaviviridae.

<i>Borrelia burgdorferi</i> Species of bacteria

Borrelia burgdorferi is a bacterial species of the spirochete class in the genus Borrelia, and is one of the causative agents of Lyme disease in humans. Along with a few similar genospecies, some of which also cause Lyme disease, it makes up the species complex of Borrelia burgdorferi sensu lato. The complex currently comprises 20 accepted and 3 proposed genospecies. B. burgdorferi sensu stricto exists in North America and Eurasia and until 2016 was the only known cause of Lyme disease in North America. Borrelia species are Gram-negative.

<span class="mw-page-title-main">White-footed mouse</span> Species of mammal

The white-footed mouse is a rodent native to North America from Ontario, Quebec, Labrador, and the Maritime Provinces to the southwestern United States and Mexico. In the Maritimes, its only location is a disjunct population in southern Nova Scotia. It is also known as the woodmouse, particularly in Texas.

<i>Dermacentor variabilis</i> Species of tick

Dermacentor variabilis, also known as the American dog tick or wood tick, is a species of tick that is known to carry bacteria responsible for several diseases in humans, including Rocky Mountain spotted fever and tularemia. It is one of the best-known hard ticks. Diseases are spread when it sucks blood from the host. It may take several days for the host to experience symptoms.

Relapsing fever is a vector-borne disease caused by infection with certain bacteria in the genus Borrelia, which is transmitted through the bites of lice, soft-bodied ticks, or hard-bodied ticks.

<i>Borrelia</i> Genus of bacteria

Borrelia is a genus of bacteria of the spirochete phylum. Several species cause Lyme disease, also called Lyme borreliosis, a zoonotic, vector-borne disease transmitted by ticks. Other species of Borrelia cause relapsing fever, and are transmitted by ticks or lice, depending on the species of bacteria. A few Borrelia species as Candidatus Borrelia mahuryensis harbor intermediate genetic features between Lyme disease and relapsing fever Borrelia. The genus is named after French biologist Amédée Borrel (1867–1936), who first documented the distinction between a species of Borrelia, B. anserina, and the other known type of spirochete at the time, Treponema pallidum. This bacterium must be viewed using dark-field microscopy, which make the cells appear white against a dark background. Borrelia species are grown in Barbour-Stoenner-Kelly medium. Of 52 known species of Borrelia, 20 are members of the Lyme disease group, 29 belong to the relapsing fever group, and two are members of a genetically distinct third group typically found in reptiles. A proposal has been made to split the Lyme disease group based on genetic diversity and move them to their own genus, Borelliella, but this change is not widely accepted. This bacterium uses hard and soft ticks and lice as vectors. Testing for the presence of the bacteria in a human includes two-tiered serological testing, including immunoassays and immunoblotting.

<span class="mw-page-title-main">Lyme disease microbiology</span>

Lyme disease, or borreliosis, is caused by spirochetal bacteria from the genus Borrelia, which has 52 known species. Three main species are the main causative agents of the disease in humans, while a number of others have been implicated as possibly pathogenic. Borrelia species in the species complex known to cause Lyme disease are collectively called Borrelia burgdorferisensu lato (s.l.) not to be confused with the single species in that complex Borrelia burgdorferi sensu stricto which is responsible for nearly all cases of Lyme disease in North America.

<i>Ixodes scapularis</i> Species of tick

Ixodes scapularis is commonly known as the deer tick or black-legged tick, and in some parts of the US as the bear tick. It was also named Ixodes dammini until it was shown to be the same species in 1993. It is a hard-bodied tick found in the eastern and northern Midwest of the United States as well as in southeastern Canada. It is a vector for several diseases of animals, including humans and is known as the deer tick owing to its habit of parasitizing the white-tailed deer. It is also known to parasitize mice, lizards, migratory birds, etc. especially while the tick is in the larval or nymphal stage.

Allen Caruthers Steere is an American rheumatologist. He is a professor of rheumatology at Harvard University and previously at Tufts University and Yale University. Steere and his mentor, Stephen Malawista of Yale University, are credited with discovering and naming Lyme disease, and he has published almost 300 scholarly articles on Lyme disease during his more than 40 years of studies of this infection. At a ceremony in Hartford, Connecticut in 1998, Governor John G. Rowland declared September 24 to be "Allen C. Steere Day".

<span class="mw-page-title-main">Virulence-related outer membrane protein family</span>

Virulence-related outer membrane proteins, or outer surface proteins (Osp) in some contexts, are expressed in the outer membrane of gram-negative bacteria and are essential to bacterial survival within macrophages and for eukaryotic cell invasion.

<span class="mw-page-title-main">Southern tick-associated rash illness</span> Medical condition

Southern tick-associated rash illness (STARI) is an emerging infectious disease related to Lyme disease that occurs in southeastern and south-central United States. It is spread by tick bites and it was hypothesized that the illness was caused by the bacteria Borrelia lonestari. However, there is insufficient evidence to declare this Borrelia strain as a causative agent.

<span class="mw-page-title-main">Human granulocytic anaplasmosis</span> Medical condition

Human granulocytic anaplasmosis (HGA) is a tick-borne, infectious disease caused by Anaplasma phagocytophilum, an obligate intracellular bacterium that is typically transmitted to humans by ticks of the Ixodes ricinus species complex, including Ixodes scapularis and Ixodes pacificus in North America. These ticks also transmit Lyme disease and other tick-borne diseases.

Ticks are insects known for attaching to and sucking blood from land-dwelling animals. Ticks fall under the category of 'arthropod', and while they are often thought of in the context of disease transmission, they are also known to cause direct harm to hosts through bites, toxin release, and infestation. Infestation can cause symptoms ranging from mild to severe and may even cause death. Hosts can include any number of vertebrates, though humans and livestock are more likely to be the interest of researchers.

<i>Ornithodoros moubata</i> Species of tick

Ornithodoros moubata, commonly known as the African hut tampan or the eyeless tampan, is a species of tick in the family Argasidae. It is an ectoparasite and vector of relapsing fever in humans, and African swine fever in pigs.

<i>Ixodes persulcatus</i> Species of tick

Ixodes persulcatus, the taiga tick, is a species of hard-bodied tick distributed from Europe through central and northern Asia to the People's Republic of China and Japan. The sexual dimorphism of the species is marked, the male being much smaller than the female. Hosts include wild and domestic ungulates, man, dog, rabbit, and other small mammals, including the dormouse, Amur hedgehog, and occasionally birds.

Borrelia spielmanii is a spirochete bacterium; it routinely infects Ixodes ricinus, and subsequently humans, causing Lyme disease.

Borrelia lusitaniae is a bacterium of the spirochete class of the genus Borrelia, which has a diderm (double-membrane) envelope. It is a part of the Borrelia burgdorferisensu lato genospecies and is a Gram-negative bacterium. B. lusitaniae is tick-borne; he type strain is PotiB2. It can be pathogenic, being involved in cases of Lyme borreliosis. A species of tick, Ixodes ricinus, is the host of B. lusitaniae. It is thought to have originated from Portugal and has since spread to parts of Europe and North Africa. Lizards of the family Lacertidae are now believed to be important reservoir hosts of this bacterium.

Borrelia andersonii is a spirochete bacterium. It can be pathogenic, being involved in cases of Lyme borreliosis.

Borrelia mayonii is a Gram-negative, host-associated spirochete that is capable of causing Lyme disease. This organism can infect various vertebrate hosts such as humans via the bite of a black legged tick.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 Della-Giustina, David; Duke, Charles; Goldflam, Katja (2021-06-01). "Underrecognized Tickborne Illnesses: Borrelia Miyamotoi and Powassan Virus". Wilderness & Environmental Medicine. 32 (2): 240–246. doi: 10.1016/j.wem.2021.01.005 . ISSN   1080-6032. PMID   33839017. S2CID   233212517.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Cutler, Sally; Vayssier-Taussat, Muriel; Estrada-Peña, Agustín; Potkonjak, Aleksandar; Mihalca, Andrei Daniel; Zeller, Hervé (2019-05-02). "A new Borrelia on the block: Borrelia miyamotoi – a human health risk?". Eurosurveillance. 24 (18): 1800170. doi:10.2807/1560-7917.ES.2019.24.18.1800170. ISSN   1560-7917. PMC   6505184 . PMID   31064634.
  3. "Etymologia: Borrelia miyamotoi". Emerging Infectious Diseases. 20 (8): 1390. 1 July 2014. doi: 10.3201/eid2008.et2008 . PMC   4111182 . S2CID   44613963.
  4. Rodino, Kyle G.; Theel, Elitza S.; Pritt, Bobbi S. (2020-04-01). "Tick-Borne Diseases in the United States". Clinical Chemistry. 66 (4): 537–548. doi: 10.1093/clinchem/hvaa040 . ISSN   1530-8561. PMID   32232463.
  5. 1 2 3 4 5 6 7 8 9 10 11 Kubiak, Katarzyna; Szczotko, Magdalena; Dmitryjuk, Małgorzata (2021-01-12). "Borrelia miyamotoi—An Emerging Human Tick-Borne Pathogen in Europe". Microorganisms. 9 (1): 154. doi: 10.3390/microorganisms9010154 . ISSN   2076-2607. PMC   7827671 . PMID   33445492.
  6. 1 2 Talagrand-Reboul, Emilie; Boyer, Pierre H.; Bergström, Sven; Vial, Laurence; Boulanger, Nathalie (2018). "Relapsing Fevers: Neglected Tick-Borne Diseases". Frontiers in Cellular and Infection Microbiology. 8: 98. doi: 10.3389/fcimb.2018.00098 . PMC   5893795 . PMID   29670860.
  7. Stone, Brandee L.; Brissette, Catherine A. (2017). "Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for Borrelia miyamotoi". Frontiers in Immunology. 8: 12. doi: 10.3389/fimmu.2017.00012 . PMC   5243832 . PMID   28154563.
  8. 1 2 3 Burde, Jed; Bloch, Evan M.; Kelly, Jill R.; Krause, Peter J. (3 April 2023). "Human Borrelia miyamotoi Infection in North America". Pathogens. 12 (4): 553. doi: 10.3390/pathogens12040553 . PMC   10145171 .
  9. 1 2 3 Hoornstra, Dieuwertje; Azagi, Tal; van Eck, Jacqueline A; Wagemakers, Alex; Koetsveld, Joris; Spijker, René; Platonov, Alexander E; Sprong, Hein; Hovius, Joppe W (October 2022). "Prevalence and clinical manifestation of Borrelia miyamotoi in Ixodes ticks and humans in the northern hemisphere: a systematic review and meta-analysis". The Lancet Microbe. 3 (10): e772–e786. doi:10.1016/S2666-5247(22)00157-4.
  10. Krause, P. J.; Fish, D.; Narasimhan, S.; Barbour, A. G. (2015-07-01). "Borrelia miyamotoi infection in nature and in humans". Clinical Microbiology and Infection. 21 (7): 631–639. doi:10.1016/j.cmi.2015.02.006. ISSN   1198-743X. PMC   4470780 . PMID   25700888.

https://www.mayocliniclabs.com/test-catalog/overview/618298